Keywords: ipsen, six-month, net, income, drops, profits, first
Ipsen's six-month net income drops 10%
Article | 03 September 2007
Profits for the first six months of 2007 at French drugmaker Ipsen fell 11.6% to 78.0 million euros ($108.4 million), equivalent to earnings per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
